Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs

Synthetic cannabinoid receptor agonists (SCRAs) constitute the largest and most defiant group of abuse designer drugs. These new psychoactive substances (NPS), developed as unregulated alternatives to cannabis, have potent cannabimimetic effects and their use is usually associated with episodes of p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2023-08, Vol.164, p.114934-114934, Article 114934
Hauptverfasser:	Gioé-Gallo, Claudia, Ortigueira, Sandra, Brea, José, Raïch, Iu, Azuaje, Jhonny, Paleo, M. Rita, Majellaro, Maria, Loza, María Isabel, Salas, Cristian O., García-Mera, Xerardo, Navarro, Gemma, Sotelo, Eddy
Format:	Artikel
Sprache:	eng
Schlagworte:	Abuse drugs Cannabinoids CB1 CB2 Designer drugs Indazole Indole SCRAs Synthetic cannabinoid receptor agonists Synthetic cannabinoids NPS
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!